Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation

Castel, D., Kergrohen, T., Tauziède-Espariat, A., Mackay, A., Ghermaoui, S., Lechapt, E., … Debily, M. A. (2020). Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation. Acta Neuropathologica, 139(6), 1109–1113. https://doi.org/10.1007/s00401-020-02142-w